Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Solesence (SLSN) Shares Outstanding (2016 - 2026)

Solesence filings provide 17 years of Shares Outstanding readings, the most recent being $70.6 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 0.75% to $70.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $70.6 million, a 0.75% increase, with the full-year FY2025 number at $70.6 million, up 0.73% from a year prior.
  • Shares Outstanding hit $70.6 million in Q1 2026 for Solesence, roughly flat from $70.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $70.6 million in Q1 2026 to a low of $49.0 million in Q1 2022.
  • Median Shares Outstanding over the past 5 years was $54.9 million (2024), compared with a mean of $59.5 million.
  • Biggest five-year swings in Shares Outstanding: increased 0.62% in 2023 and later skyrocketed 41.26% in 2024.
  • Solesence's Shares Outstanding stood at $49.3 million in 2022, then increased by 0.62% to $49.6 million in 2023, then surged by 41.26% to $70.1 million in 2024, then grew by 0.73% to $70.6 million in 2025, then increased by 0.03% to $70.6 million in 2026.
  • The last three reported values for Shares Outstanding were $70.6 million (Q1 2026), $70.6 million (Q4 2025), and $70.5 million (Q3 2025) per Business Quant data.